2 strong blue chip ASX shares rated as buys by brokers

These 2 blue chip ASX shares are rated as buys by brokers. One of those ideas is biotech healthcare giant CSL Limited (ASX:CSL).

| More on:
best fintech asx shares represented by businessman flexing biceps

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Blue chip ASX shares can make good investments and some brokers have been scouring the market for the best ones to own.

The idea is that the broker will try to find the opportunities that might do well over the next 12 months – so then a price target is assigned. The bigger the price target, the stronger the return might be over the next year.

These two blue chip ASX shares are ones that leading brokers like:

CSL Limited (ASX: CSL)

CSL is actually one of the biggest blue chip shares on the ASX. It has a market capitalisation well over $100 billion.

One of the brokers that likes the CSL share price right now is UBS. Whilst the interim report was strong, the broker doesn't think the following six months will be as good.

A key reason for the weaker expectation is that plasma collections are suffering and may not turn around until near the end of FY21.

One of the things that may help CSL is when COVID-19 vaccines have been deployed. However there is a while to go with this.

The blue chip ASX share is reporting some strength in its Seqirus business which CSL said delivered an exceptionally strong performance in the first six months of the financial year.

CSL did say that its performance is being supported by its diversified and resilient business model.

In the first half of FY21 it made $1.81 billion of net profit after tax (NPAT). Full year profit for FY21 is expected to be between $2.17 billion to $2.265 billion, which would be growth of up to 8% in constant currency terms, despite all of the impacts.

UBS has a price target of $310 for CSL shares, which would be growth of almost 30%.

Fortescue Metals Group Limited (ASX: FMG)

Fortescue is now one of the world's biggest iron ore miners and it's still rated as a buy by the brokers at Macquarie Group Ltd (ASX: MQG).

The blue chip ASX share is benefiting from the high iron ore prices and this is sending the net profit surging higher.

In the FY21 half-year result, revenue jumped 44% to $9.3 billion, underlying earnings before interest, tax, depreciation and amortisation (EBITDA) rose 57% to $6.6 billion and net profit after tax grew 66% to $4.08 billion. This funded a 93% increase of the dividend to AU$1.47 per share.

Fortescue has announced it plans to shift its business to greener initiatives sooner than expected with a goal of being carbon neutral by 2030.

Some of the plans include green hydrogen, renewable energy and green ammonia. It's looking for these types of projects across Australia and the world. Fortescue is looking to reduce its own footprint with getting rid of diesel consumption.

Macquarie doesn't think that FY22 will be as strong as FY21. So, for FY22, Macquarie is predicting that Fortescue can generate $2.42 of earnings per share (EPS) and that it's going to pay a dividend of $1.94 per share. That would translate into a forward grossed-up dividend yield of 13.6%. Macquarie has a price target of $25.50 for Macquarie. 

Tristan Harrison owns shares of Fortescue Metals Group Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Blue Chip Shares

2 high-quality ASX shares to buy after the market sell-off

Could this market sell-off be a buying opportunity for investors? Here are two shares analysts rate as buys.

Read more »

a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.
Blue Chip Shares

2 of the best ASX 200 blue-chip shares to buy now

Analysts think these blue chips could be best buys this month.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Blue Chip Shares

These ASX 200 shares could rise 25% to 35%

Analysts believe these shares could rise strongly from current levels.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

4 ASX 200 blue chip shares to buy now

Analysts say these high-quality companies are top buys in April.

Read more »

Confident male executive dressed in a dark blue suit leans against a doorway with his arms crossed in the corporate office
Blue Chip Shares

Why I'd confidently buy these 3 ASX blue-chips while others grow fearful

As legendary investor Warren Buffett famously advises, “Be greedy when others are fearful.”

Read more »

Seven men and women of different ages and nationalities put their heads together and smile as they look down at the camera.
Blue Chip Shares

2 ASX shares I'd buy to quickly add diversification

I like these stocks for Aussies wanting different blue-chip exposure.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Blue Chip Shares

Buy these fantastic blue chip ASX 200 shares in April

Analysts have put buy ratings on these high quality blue chips.

Read more »

Person holding a blue chip.
Blue Chip Shares

2 ASX blue-chip shares I'd buy with $3,000 right now

These are large businesses with compelling futures.

Read more »